SEP 1·investing.comLow
Entrata files for proposed IPO
Entrata (ENT) filed for a proposed IPO on the NYSE. Goldman Sachs, J.P. Morgan, and Barclays will serve as lead underwriters. The filing marks a step toward the company's public debut.
Stock
$ENT
ENTRATA, INC.
Price · $ENTvia TradingView
AI sentiment · 7d0 articles
No enriched coverage for $ENT in the last 7 days.
Insider · 30dAll trades →
No SEC Form 4 filings for $ENT in the last 30 days.
See all $ENT insider activity →Top stories · $ENTMore →
AUG 14·investments.halifax.co.uk
Halifax – Market news
Sharecast reports FTSE 100 movers. Pharmaceutical and tobacco stocks fell, with GSK, AstraZeneca, BAT and Imperial Brands among the weakest. Gains included Experian, Sage Group and Relx, linked to a Reuters report on Silver Lake talks to buy Workday. IG Group rose after RBC reiterated ‘outperform’ and kept a 1,850p target, citing oversold shares post Underdog acquisition.
AUG 13·share-talk.com
RNS Hotlist with Zak Mir: ETHY, SVS, RNK, ENT, TERA, DIS, ENET, BZT, OBD & SKA
The article is a hotlist of UK-listed company updates. Ethtry PLC agreed heads of terms to buy 100% of Dunbar Energy for an indicative combined pre-money equity value of US$15m. Savills reported 6-month revenue up 9% and underlying PBT up 47%. Rank, Entain, NeoTerra, Distil, Ethernity, Bezant, and Oxford BioDynamics also issued trading, interim, or project updates.
ENT sentiment & insider activity
Recent ENT coverage spans market movers, ipo and financial news.
What's driving ENT
Entrata (ENT) filed for a proposed IPO on the NYSE. Goldman Sachs, J.P. Morgan, and Barclays will serve as lead underwriters. The filing marks a step toward the company's public debut.
The article does not disclose a tradable, company-specific driver for Entain.
ENT’s interim print shows outperformance versus expectations, but the article provides no new guidance beyond the interim period.
Entain’s decline appears driven by general market pullback, not a new Entain catalyst.
The deal reduces Entain’s ownership (67.5%→47.5%), shifts Entain CEE to minority accounting, and uses proceeds to cut debt/leverage.
alphai scores every news story that mentions ENT with an AI model for sentiment and relevance, and aggregates insider trades from ENTRATA, INC.'s SEC EDGAR Form 4 filings. Figures refresh continuously.
News on $ENT
Score
Entrata files for proposed IPO
Entrata (ENT) filed for a proposed IPO on the NYSE. Goldman Sachs, J.P. Morgan, and Barclays will serve as lead underwriters. The filing marks a step toward the company's public debut.
1 min read
Halifax – Market news
Sharecast reports FTSE 100 movers. Pharmaceutical and tobacco stocks fell, with GSK, AstraZeneca, BAT and Imperial Brands among the weakest. Gains included Experian, Sage Group and Relx, linked to a Reuters report on Silver Lake talks to buy Workday. IG Group rose after RBC reiterated ‘outperform’ and kept a 1,850p target, citing oversold shares post Underdog acquisition.
3 min read
RNS Hotlist with Zak Mir: ETHY, SVS, RNK, ENT, TERA, DIS, ENET, BZT, OBD & SKA
The article is a hotlist of UK-listed company updates. Ethtry PLC agreed heads of terms to buy 100% of Dunbar Energy for an indicative combined pre-money equity value of US$15m. Savills reported 6-month revenue up 9% and underlying PBT up 47%. Rank, Entain, NeoTerra, Distil, Ethernity, Bezant, and Oxford BioDynamics also issued trading, interim, or project updates.
7 min readFTSE 100 Live: London stocks decline, gold rises on easing Fed fears
London’s FTSE 100 was down about 26 points to ~10,627 as investors trimmed gains after a weaker US jobs report eased Federal Reserve rate-hike expectations. Gold rose ~1.5% to $4,183.92/oz. InterContinental Hotels Group, Tesco and Entain fell, while Fresnillo gained. Samsung helped lift Asian tech stocks after reports of an Anthropic custom AI chip.
4 min read
Phased exit of Entain CEE - 20% divestment agreed
Entain said it agreed to sell a 20% interest in Entain Holdings (CEE) Ltd to joint venture partner EMMA Capital in a phased exit. The deal values Entain CEE at about €2.1bn (c.10x EBITDA) and provides ~€425m cash, including €395m on completion plus an early-2027 payment. Net proceeds will reduce debt; completion is expected in Q4 2026.
6 min read